𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chronic treatment and withdrawal of the cannabinoid agonist WIN 55,212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain

✍ Scribed by David Moranta; Susana Esteban; Jesús A. García-Sevilla

Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
328 KB
Volume
379
Category
Article
ISSN
0028-1298

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cannabinoid agonist WIN55,212-2 induces
Cannabinoid agonist WIN55,212-2 induces apoptosis in cerebellar granule cells via activation of the CB1 receptor and downregulation of bcl-xL gene expression
✍ Giacomo Pozzoli; Giuseppe Tringali; Mauro Vairano; Monia D'Amico; Pierluigi Nava 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB

## Abstract The endogenous cannabinoid system is involved in the regulation of a number of physiologic effects in both the central and peripheral nervous systems. Its role in the control of neuronal cell proliferation has attracted major attention because of its potential implications for new thera

Acute, chronic and withdrawal effects of
Acute, chronic and withdrawal effects of the cannabinoid receptor agonist WIN55212-2 on the sequential activation of MAPK/Raf-MEK-ERK signaling in the rat cerebral frontal cortex: Short-term regulation by intrinsic and extrinsic pathways
✍ David Moranta; Susana Esteban; Jesús A. García-Sevilla 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB

## Abstract The cannabinoids (CB) modulate the extracellular signal‐regulated kinase (ERK), leading to various forms of plasticity in the brain. Little is known, however, on the in vivo short‐ and long‐term activation and regulation of the components of mitogen‐activated protein kinase (MAPK)/ERK s